OPEN APP
Home / Companies / News /  Pfizer CEO joins host of executives at Covid-19 vaccine makers in big stock sale

Pfizer CEO joins host of executives at Covid-19 vaccine makers in big stock sale

FILE - In this Feb. 26, 2019 file photo, Albert Bourla, chief executive officer of Pfizer, prepares to testify before the Senate Finance Committee hearing on drug prices, on Capitol Hill in Washington. On Monday, Nov. 9, 2020, Pfizer said that an early peek at the data on its coronavirus vaccine suggests the shots may be a surprisingly robust 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration. (AP Photo/Pablo Martinez Monsivais, File) (AP)Premium
FILE - In this Feb. 26, 2019 file photo, Albert Bourla, chief executive officer of Pfizer, prepares to testify before the Senate Finance Committee hearing on drug prices, on Capitol Hill in Washington. On Monday, Nov. 9, 2020, Pfizer said that an early peek at the data on its coronavirus vaccine suggests the shots may be a surprisingly robust 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration. (AP Photo/Pablo Martinez Monsivais, File) (AP)
wsj

Albert Bourla sold about 60% of his personal shares after positive vaccine news this week; sale’s price and volume had been authorized in a February planning move

The timing this week of Pfizer Inc. Chief Executive Albert Bourla’s sale of about $5.6 million in company shares—on the same day it announced positive results from its Covid-19 vaccine—is drawing scrutiny from some investors.

Close
Recommended For You
×
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout